Search Results
Search for other papers by Eyun Song in
Google Scholar
PubMed
Search for other papers by Dong Eun Song in
Google Scholar
PubMed
Search for other papers by Jonghwa Ahn in
Google Scholar
PubMed
Search for other papers by Tae Yong Kim in
Google Scholar
PubMed
Search for other papers by Won Bae Kim in
Google Scholar
PubMed
Search for other papers by Young Kee Shong in
Google Scholar
PubMed
Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
lymph node metastases, and increased cancer-related mortality ( Kim et al. 2012 , Li et al. 2012 , Xing et al. 2013 ). Genetic alterations involving RAS -family genes comprise another distinct feature of DTCs ( Nikiforov 2008 , Prior et al
Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Alberto Cascón in
Google Scholar
PubMed
Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Lucía Inglada-Pérez in
Google Scholar
PubMed
Search for other papers by Iñaki Comino-Méndez in
Google Scholar
PubMed
Search for other papers by Aguirre A de Cubas in
Google Scholar
PubMed
Search for other papers by Rocío Letón in
Google Scholar
PubMed
Search for other papers by Jaume Mora in
Google Scholar
PubMed
Search for other papers by Mónica Marazuela in
Google Scholar
PubMed
Search for other papers by Juan Carlos Galofré in
Google Scholar
PubMed
Search for other papers by Miguel Quesada-Charneco in
Google Scholar
PubMed
Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Department of Pediatric Oncology, Endocrinology Division, Department of Endocrinology and Nutrition, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
patients develop extra-adrenal tumors ( Cascon et al . 2009 b , Mannelli et al . 2009 ), the percentage of malignant cases depends on tumor location and/or genetic background (from ∼3% in RET- or VHL-related cases to 31% described for SDHB mutation
Search for other papers by A Perren in
Google Scholar
PubMed
Search for other papers by S Schmid in
Google Scholar
PubMed
Search for other papers by T Locher in
Google Scholar
PubMed
Search for other papers by P Saremaslani in
Google Scholar
PubMed
Search for other papers by C Bonvin in
Google Scholar
PubMed
Search for other papers by P U Heitz in
Google Scholar
PubMed
Search for other papers by P Komminoth in
Google Scholar
PubMed
tumors including pheochromocytomas (PCCs), paragangliomas (PGLs) and medullary thyorid carcinomas (MTCs) evolve from neural-crest-derived cells ( Pasini et al. 1996 ). Secondly, on a molecular genetic level, activation of tyrosine kinases ( Ret
Search for other papers by Silvia Pizzi in
Google Scholar
PubMed
Search for other papers by Cinzia Azzoni in
Google Scholar
PubMed
Search for other papers by Elisa Tamburini in
Google Scholar
PubMed
Search for other papers by Lorena Bottarelli in
Google Scholar
PubMed
Search for other papers by Nicoletta Campanini in
Google Scholar
PubMed
Search for other papers by Tiziana D'Adda in
Google Scholar
PubMed
Search for other papers by Giovanni Fellegara in
Google Scholar
PubMed
Search for other papers by Tu Vinh Luong in
Google Scholar
PubMed
Search for other papers by Claudio Pasquali in
Google Scholar
PubMed
Search for other papers by Giulio Rossi in
Google Scholar
PubMed
Search for other papers by Gianfranco Delle Fave in
Google Scholar
PubMed
Search for other papers by Roberta Camisa in
Google Scholar
PubMed
Search for other papers by Cesare Bordi in
Google Scholar
PubMed
Search for other papers by Guido Rindi in
Google Scholar
PubMed
2003 Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract . Cancer 98 1273 – 1282 . Pizzi S Azzoni C Bottarelli L Campanini N D'Adda T Pasquali C Rossi G Rindi G Bordi C 2005 RASSF1
Search for other papers by Nitya Raj in
Google Scholar
PubMed
Search for other papers by Youyun Zheng in
Google Scholar
PubMed
Search for other papers by Haley Hauser in
Google Scholar
PubMed
Search for other papers by Joanne Chou in
Google Scholar
PubMed
Search for other papers by Johnathan Rafailov in
Google Scholar
PubMed
Search for other papers by Jad Bou-Ayache in
Google Scholar
PubMed
Search for other papers by Peter Sawan in
Google Scholar
PubMed
Search for other papers by Jamie Chaft in
Google Scholar
PubMed
Search for other papers by Jennifer Chan in
Google Scholar
PubMed
Search for other papers by Kimberly Perez in
Google Scholar
PubMed
Search for other papers by Charles Rudin in
Google Scholar
PubMed
Search for other papers by Laura Tang in
Google Scholar
PubMed
Search for other papers by Diane Reidy-Lagunes in
Google Scholar
PubMed
during treatment with ribociclib and everolimus. In correlative analyses, there was no association between genetic alterations in the tumor of patients experiencing disease stabilization vs progressive disease during treatment with this drug combination
Search for other papers by Rushabh Gujarathi in
Google Scholar
PubMed
Search for other papers by Sara Abou Azar in
Google Scholar
PubMed
Search for other papers by Joseph Tobias in
Google Scholar
PubMed
Search for other papers by Blase N Polite in
Google Scholar
PubMed
Search for other papers by Namrata Setia in
Google Scholar
PubMed
Search for other papers by Nicholas Feinberg in
Google Scholar
PubMed
Search for other papers by Daniel E Appelbaum in
Google Scholar
PubMed
Search for other papers by Xavier M Keutgen in
Google Scholar
PubMed
Search for other papers by Chih-Yi Liao in
Google Scholar
PubMed
chromatin binding of the p53 protein ( Gulve et al. 2022 ). In a clinical context, considering the potential interaction between these genetic alterations and the tumor genotype of TP53 alongside the MEN1 / DAXX / ATRX mutational status could offer
Department of Pathology, WRN219, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114, USA
Search for other papers by Peter M Sadow in
Google Scholar
PubMed
Search for other papers by Dora Dias-Santagata in
Google Scholar
PubMed
Search for other papers by Zongli Zheng in
Google Scholar
PubMed
Search for other papers by Derrick T Lin in
Google Scholar
PubMed
Search for other papers by Long Phi Le in
Google Scholar
PubMed
Search for other papers by Carmelo Nucera in
Google Scholar
PubMed
known to be present in 27 of these patients while alive. In most patients, lung metastases are detected by chest X-ray ( Besic & Gazic 2013 ). Several genetic alterations are reported in the pathogenesis of ATC, including RAS , BRAF , TP53 , CTNNB1
Search for other papers by Kyle M Walsh in
Google Scholar
PubMed
Search for other papers by Murim Choi in
Google Scholar
PubMed
Search for other papers by Kjell Oberg in
Google Scholar
PubMed
Search for other papers by Matthew H Kulke in
Google Scholar
PubMed
Search for other papers by James C Yao in
Google Scholar
PubMed
Search for other papers by Chengqing Wu in
Google Scholar
PubMed
Search for other papers by Magdalena Jurkiewicz in
Google Scholar
PubMed
Search for other papers by Ling-I Hsu in
Google Scholar
PubMed
Search for other papers by Susanne M Hooshmand in
Google Scholar
PubMed
Search for other papers by Manal Hassan in
Google Scholar
PubMed
Search for other papers by Eva T Janson in
Google Scholar
PubMed
Search for other papers by Janet L Cunningham in
Google Scholar
PubMed
Search for other papers by Evan Vosburgh in
Google Scholar
PubMed
Search for other papers by Richard S Sackler in
Google Scholar
PubMed
Search for other papers by Richard P Lifton in
Google Scholar
PubMed
Search for other papers by Andrew T DeWan in
Google Scholar
PubMed
Search for other papers by Josephine Hoh in
Google Scholar
PubMed
list of the most commonly reported chromosomal alterations was compiled, and a meta-analysis of the prevalence of this alteration in patients with ileal carcinoids was performed. As different genetic alterations may distinguish localized ileal carcinoid
Search for other papers by Olga Karapanou in
Google Scholar
PubMed
Department of Clinical Therapeutics, Alexandra Hospital Athens University School of Medicine, Endocrine Unit, Athens, Greece
Search for other papers by George Simeakis in
Google Scholar
PubMed
Search for other papers by Barbara Vlassopoulou in
Google Scholar
PubMed
Search for other papers by Maria Alevizaki in
Google Scholar
PubMed
Search for other papers by Katerina Saltiki in
Google Scholar
PubMed
. 2020 ). Not only common genetic modifications but also epigenetic alterations may underlie the spectrum of biological behavior of these neoplasms ( Asa & Ezzat 2018 ). The main targets of molecular alterations that have been implicated in the
Search for other papers by Soazig Le Pennec in
Google Scholar
PubMed
Search for other papers by Tomasz Konopka in
Google Scholar
PubMed
Search for other papers by David Gacquer in
Google Scholar
PubMed
Search for other papers by Danai Fimereli in
Google Scholar
PubMed
Search for other papers by Maxime Tarabichi in
Google Scholar
PubMed
Search for other papers by Gil Tomás in
Google Scholar
PubMed
IRIBHM, WELBIO, CHU d'Angers, EA 3143, Service d'Anatomie et Cytologie Pathologiques, Hôpital Pitié-Salpêtrière, Institut Jules Bordet, Université libre de Bruxelles (ULB), Campus Erasme, 808 Route de Lennik, 1070 Brussels, Belgium
Search for other papers by Frédérique Savagner in
Google Scholar
PubMed
Search for other papers by Myriam Decaussin-Petrucci in
Google Scholar
PubMed
Search for other papers by Christophe Trésallet in
Google Scholar
PubMed
Search for other papers by Guy Andry in
Google Scholar
PubMed
Search for other papers by Denis Larsimont in
Google Scholar
PubMed
Search for other papers by Vincent Detours in
Google Scholar
PubMed
IRIBHM, WELBIO, CHU d'Angers, EA 3143, Service d'Anatomie et Cytologie Pathologiques, Hôpital Pitié-Salpêtrière, Institut Jules Bordet, Université libre de Bruxelles (ULB), Campus Erasme, 808 Route de Lennik, 1070 Brussels, Belgium
Search for other papers by Carine Maenhaut in
Google Scholar
PubMed
the basis of multiple genetic alterations, i.e. non-synonymous single-nucleotide variants (nsSNVs), gene fusions, alternative transcripts, and loss of heterozygosity (LOH). Materials and methods Case description A 71-year-old male was diagnosed with a